Over time, the use of hormone therapy in prostate cancer life expectancy has been based on the demonstration that such androgen actions target malignant prostate cells. Patients weighing their treatment options for localized intermediate and high-risk cancer often find it difficult to choose from the various options available. Standard treatment procedures involve the radiation therapies and medications that block testosterone, a male hormone that promotes the growth of cancer cells in the prostate.

Unfortunately, cancer drugs come with serious side effects, including impotence, loss of muscle mass, and fatigue. Since radiation doesn’t treat prostate cancer fully without these drugs, doctors currently prefer combining it with hormone therapy. This is backed by a study from the New England Journal of Medicine indicating that patients who undergo hormone therapy are likely to survive longer, especially after surgery. 

Better Results Seen with Hormone Therapy

Radiation therapy is a crucial phase in treating prostate cancer as it eliminates any cancer cells that may remain after prostatectomy. Like the use of CBD oil for pain management in cancer, radiation only treats cancer cells localized in the pelvis, where the initial cancerous cells were located. Unlike radiation, hormone therapy treats cancerous cells in every part of the body and enhances the effects of radiation.

According to this leading research published in the New England Journal, the study concluded that prostate cancer patients using a combination of radiation and androgen therapy for 24 years significantly decreased death rates. So to say, less than 6 percent of patients who received hormone therapy die from prostate cancer after 12 years. On the other hand, 13% of patients who did not receive the combined radiation and hormone therapy died. Additionally, patients who used hormone therapy had a 9 percent reduced rate of developing metastatic prostate cancer.

Better Results Seen with Hormone Therapy

Radiation therapy is a crucial phase in treating prostate cancer as it eliminates any cancer cells that may remain after prostatectomy. Like the use of CBD oil for pain management in cancer, radiation only treats cancer cells localized in the pelvis, where the initial cancerous cells were located. Unlike radiation, hormone therapy treats cancerous cells in every part of the body and enhances the effects of radiation.

According to this leading research published in the New England Journal, the study concluded that prostate cancer patients using a combination of radiation and androgen therapy for 24 years significantly decreased death rates. So to say, less than 6 percent of patients who received hormone therapy die from prostate cancer after 12 years. On the other hand, 13% of patients who did not receive the combined radiation and hormone therapy died. Additionally, patients who used hormone therapy had a 9 percent reduced rate of developing metastatic prostate cancer.

Radiation therapy is a crucial phase in treating prostate cancer as it eliminates any cancer cells that may remain after prostatectomy. Like the use of CBD oil for pain management in cancer, radiation only treats cancer cells localized in the pelvis, where the initial cancerous cells were located. Unlike radiation, hormone therapy treats cancerous cells in every part of the body and enhances the effects of radiation.

According to this leading research published in the New England Journal, the study concluded that prostate cancer patients using a combination of radiation and androgen therapy for 24 years significantly decreased death rates. So to say, less than 6 percent of patients who received hormone therapy die from prostate cancer after 12 years. On the other hand, 13% of patients who did not receive the combined radiation and hormone therapy died. Additionally, patients who used hormone therapy had a 9 percent reduced rate of developing metastatic prostate cancer.

 

As mentioned, hormone therapy in prostate cancer treatment is used to slow or prevent testosterone production from the body. Testosterone is a male hormone that stimulates the growth of cancer cells in the prostate. Therefore, cancer specialists can recommend using hormone therapy at different times for different reasons during the treatment phase. Hormone therapy is best for several situations.

Patients with advanced or metastatic prostate cancer are the first eligible group for this therapy. Hormone therapy helps shrink and slow the growth of tumors. This relieves the signs and symptoms of cancer. Secondly, it suits patients whose levels of prostate-specific antigen remain high or start increasing after treatment of prostate cancer.

Hormone therapy is also beneficial in increasing the effectiveness of radiation therapy in patients with local prostate cancer. Physicians also prescribe for patients with high risks of cancer recurrence after the first treatment. This is because it helps in suppressing the cancerous cells.

Treatment Options for Hormone Therapy

The use of hormone therapy in the treatment of prostate cancer can be achieved in three ways. The first approach is the use of medications that stop testosterone production in the body. Some medications, such as gonadotropin or luteinizing hormone agonist and antagonist, can be used to prevent testosterone production in the body.

Doctors can secondly use medications that block testosterone hormones from making contact with cancer cells. Also known as anti-androgens, they are given alongside luteinizing hormone-releasing hormone agonist to prevent testosterone from reaching the cancerous cells. Surgery to remove the testes is the third effective way of achieving hormone therapy. It reduces the levels of testosterone hormones quickly. However, unlike medication, surgery is a permanent procedure.

Side Effects of Hormone Therapy

The use of hormone therapy in young patients with early prostate cancer and long periods requires a careful evaluation of the indications. Possible risks associated with this treatment option include the risks of over-Treatment, developing a hormone-refractory disease, affects quality of life, leads to bone thinning, erectile dysfunction, and increased body fat.

Men with significant pre-existing conditions, such as heart problems and diabetes, often experience serious side effects or report worsening of previous conditions. To reduce hormone therapy’s possible consequences, doctors often recommend using them for a specific period or until the PSA levels are low.

However, patients may need to resume using this therapy if cancer progresses or recurs. Several studies have shown that intermittent dosing of medications used for hormone therapy can also reduce the risks of developing side effects.

Conclusion

Prostate cancer, like any other form of cancer, is on the rise. So to say, there are about 200,000 diagnoses made in the U.S. every year. Of these, 75,000 undergo a prostatectomy, but 30% of them experience a surge in PSA levels, even after the surgery. In such situations, doctors often opt for radiation therapy to eliminate recurrence. However, hormone therapy’s inclusion during radiation has demonstrated better results in preventing recurrence and increased life expectancy among prostate cancer patients.